Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

HQL

Abrdn Life Sciences Investors

Financial Services · USD

Set alert

Price alert · HQL

All alert types
18.44 USD -0.30 -1.60%
As of Oct 30, 2026 Extended hours 18.44 0.00%
Bid
18.39 × 200
Ask
18.44 × 700
18.25 Day range 18.77
15.87 52-week range 22.67
YTD
+9.89%
1 year
+4.77%
Open
18.77
Prev close
18.74
Mkt cap
560.72M
Vol
86.55K
Avg vol
134.32K
EPS
6.64
P/E
2.78
Div yield
14.12%
More statistics
Low
18.25
High
18.77
Forward P/E
0.00
Beta
0.70
Short ratio
0.41
Inst. own
35.35%
Dividend
2.00
Ex-div date
Nov 20, 2024
50-d avg
14.47
200-d avg
14.34
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for HQL has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

136.14 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 5
  • P/B 4

Valuation

P/E 5.2×
FY 2016: -18.7×FY 2017: 6.7×FY 2018: 15.9×FY 2019: -5.0×FY 2020: 3.4×FY 2021: 7.8×FY 2022: -3.4×FY 2023: 15.8×FY 2024: 5.0×FY 2025: 5.2×
FY 2016 5y median 5.2× FY 2025
P/S 5.2×
FY 2016: 35.5×FY 2017: 6.6×FY 2018: 230×FY 2019: 143×FY 2020: 10.7×FY 2021: 11.2×FY 2022: 11.0×FY 2023: 9.0×FY 2024: 4.9×FY 2025: 5.2×
FY 2016 5y median 9.0× FY 2025
P/B 0.9×
FY 2016: 0.5×FY 2017: 1.0×FY 2018: 1.0×FY 2019: 0.9×FY 2020: 0.9×FY 2021: 1.0×FY 2022: 0.9×FY 2023: 0.9×FY 2024: 0.9×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
P/FCF -193×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -193×
FY 2016 5y median 0.0× FY 2025
EV/EBITDA 5.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 3.4×FY 2021: 7.4×FY 2022: -3.6×FY 2023: 14.4×FY 2024: 4.9×FY 2025: 5.2×
FY 2016 5y median 5.2× FY 2025
EV/Sales 5.2×
FY 2016: 35.5×FY 2017: 6.6×FY 2018: 230×FY 2019: 143×FY 2020: 10.9×FY 2021: 11.2×FY 2022: 11.4×FY 2023: 9.0×FY 2024: 4.9×FY 2025: 5.2×
FY 2016 5y median 9.0× FY 2025
FCF Yield -0.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -0.5%
FY 2016 5y median 0.0% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 21.3%FY 2017: 93.4%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 86.7%FY 2021: 86.5%FY 2022: 82.6%FY 2023: 46.4%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 86.5% FY 2025
Operating Margin 99.1%
FY 2016: -60.3%FY 2017: -5.6%FY 2018: -181.6%FY 2019: -118.0%FY 2020: 314.9%FY 2021: 143.3%FY 2022: -328.3%FY 2023: -13.3%FY 2024: 98.4%FY 2025: 99.1%
FY 2016 5y median 98.4% FY 2025
Net Margin 99.1%
FY 2016: -189.3%FY 2017: 98.2%FY 2018: 1443.4%FY 2019: -2887.8%FY 2020: 314.9%FY 2021: 143.3%FY 2022: -328.3%FY 2023: 56.8%FY 2024: 98.4%FY 2025: 99.1%
FY 2016 5y median 98.4% FY 2025
ROE 16.7%
FY 2016: -2.9%FY 2017: 14.7%FY 2018: 6.0%FY 2019: -18.4%FY 2020: 25.4%FY 2021: 12.3%FY 2022: -26.3%FY 2023: 5.6%FY 2024: 18.6%FY 2025: 16.7%
FY 2016 5y median 12.3% FY 2025
ROIC 16.6%
FY 2016: -0.9%FY 2017: -0.8%FY 2018: -0.8%FY 2019: -0.8%FY 2020: 25.5%FY 2021: 12.1%FY 2022: -24.9%FY 2023: -1.3%FY 2024: 18.0%FY 2025: 16.6%
FY 2016 5y median 12.1% FY 2025
ROA 16.6%
FY 2016: -2.9%FY 2017: 14.6%FY 2018: 6.0%FY 2019: -18.2%FY 2020: 25.4%FY 2021: 12.1%FY 2022: -25.2%FY 2023: 5.6%FY 2024: 18.5%FY 2025: 16.6%
FY 2016 5y median 12.1% FY 2025

Growth (YoY)

Revenue -0.3%
FY 2016: 375.7%FY 2017: 1009.6%FY 2018: -97.2%FY 2019: 22.9%FY 2020: 1500.9%FY 2021: 15.2%FY 2022: -29.2%FY 2023: 23.6%FY 2024: 120.1%FY 2025: -0.3%
FY 2016 FY 2025
Operating Income 0.3%
FY 2016: 19.7%FY 2017: -2.3%FY 2018: 7.0%FY 2019: 20.2%FY 2020: 4374.1%FY 2021: -47.6%FY 2022: -262.1%FY 2023: 95.0%FY 2024: 1726.5%FY 2025: 0.3%
FY 2016 FY 2025
EPS (diluted) -2.6%
FY 2016: -127.7%FY 2017: 663.2%FY 2018: -60.1%FY 2019: -337.5%FY 2020: 269.7%FY 2021: -48.4%FY 2022: -253.0%FY 2023: 119.4%FY 2024: 284.8%FY 2025: -2.6%
FY 2016 FY 2025
Free Cash Flow 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.7×
FY 2016: 7.6×FY 2017: 0.5×FY 2018: 4.8×FY 2019: 1.8×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.3×FY 2025: 1.7×
FY 2016 5y median 0.1× FY 2025
Quick Ratio 1.7×
FY 2016: 7.6×FY 2017: -7.3×FY 2018: 4.8×FY 2019: -4.4×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.3×FY 2025: 1.7×
FY 2016 5y median 0.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 7.1%
FY 2016: 15.2%FY 2017: 7.4%FY 2018: 8.0%FY 2019: 9.9%FY 2020: 8.4%FY 2021: 8.1%FY 2022: 10.8%FY 2023: 10.3%FY 2024: 11.0%FY 2025: 7.1%
FY 2016 5y median 10.3% FY 2025
Payout Ratio 37.0%
FY 2016: -285.1%FY 2017: 49.5%FY 2018: 127.4%FY 2019: -49.0%FY 2020: 28.5%FY 2021: 63.5%FY 2022: -36.1%FY 2023: 162.0%FY 2024: 54.6%FY 2025: 37.0%
FY 2016 5y median 54.6% FY 2025

Annual · latest fiscal year ends 2025-09-30